Explore
Validate
LearnPAB0468
antibody from Abnova Corporation
Targeting: FGFR1
BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM
Other assayAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB0468 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB0468, RRID:AB_982565
- Product name
- FGFR1 (phospho Y307) polyclonal antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal antibody raised against synthetic phosphopeptide of FGFR1.
- Storage
- Store at 4°C. For long term storage store at -20°C.Aliquot to avoid repeated freezing and thawing.
Submitted references Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
90-kDa ribosomal S6 kinase is a direct target for the nuclear fibroblast growth factor receptor 1 (FGFR1): role in FGFR1 signaling.
Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
Sato N, Katsumata N, Kagami M, Hasegawa T, Hori N, Kawakita S, Minowada S, Shimotsuka A, Shishiba Y, Yokozawa M, Yasuda T, Nagasaki K, Hasegawa D, Hasegawa Y, Tachibana K, Naiki Y, Horikawa R, Tanaka T, Ogata T
The Journal of clinical endocrinology and metabolism 2004 Mar;89(3):1079-88
The Journal of clinical endocrinology and metabolism 2004 Mar;89(3):1079-88
Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
Sato N, Katsumata N, Kagami M, Hasegawa T, Hori N, Kawakita S, Minowada S, Shimotsuka A, Shishiba Y, Yokozawa M, Yasuda T, Nagasaki K, Hasegawa D, Hasegawa Y, Tachibana K, Naiki Y, Horikawa R, Tanaka T, Ogata T
The Journal of clinical endocrinology and metabolism 2004 Mar;89(3):1079-88
The Journal of clinical endocrinology and metabolism 2004 Mar;89(3):1079-88
90-kDa ribosomal S6 kinase is a direct target for the nuclear fibroblast growth factor receptor 1 (FGFR1): role in FGFR1 signaling.
Hu Y, Fang X, Dunham SM, Prada C, Stachowiak EK, Stachowiak MK
The Journal of biological chemistry 2004 Jul 9;279(28):29325-35
The Journal of biological chemistry 2004 Jul 9;279(28):29325-35
Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
Ibrahimi OA, Zhang F, Hrstka SC, Mohammadi M, Linhardt RJ
Biochemistry 2004 Apr 27;43(16):4724-30
Biochemistry 2004 Apr 27;43(16):4724-30
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Dot blot analysis of FGFR1 (phospho Y307) polyclonal antibody (Cat # PAB0468) on nitrocellulose membrane. 50 ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentration was 0.5 ug/mL. P-Pab : phospho-antibody; P-Peptide : phospho-peptide; NP-Peptide : non-phospho-peptide.
- Validation comment
- Dot Blot (Peptide)
